Neoadjuvant semaglutide showed no benefit in weight loss, diabetes remission or safety in a cohort of patients who underwent ...

Real Housewives of New Jersey” star Jennifer Fessler didn’t follow her doctor’s advice when she started taking a GLP-1 weight ...

CHARLIE Sadler had never felt so low in his life – weighing 34 stone and stuck in a painful cycle of comfort eating he saw no ...

A DIY drink blending oats, water, cinnamon, and lime juice has amassed a cult-like following on social media. But does it ...

While gastrointestinal issues are the most common side effects, a recent study by the University of British Columbia linked ...

Dr. Michael Greger is famous for several books including “How Not to Die,” and for his website nutritionfacts.org. He ...

Eli Lilly (LLY) leads with groundbreaking tirzepatide (Mounjaro/Zepbound), while Hims & Hers Health (HIMS) faces challenges.

Hims & Hers is expanding access to Eli Lilly's branded weight loss drug Zepbound and diabetes drug Mounjaro as well as ...

The recent uptick and rise in popularity of GLP-1 drugs for addressing weight loss and obesity has led to an increase in U.S. litigation ...

People seem to be less impressed when others lose weight with the drug Ozempic than when they achieve it via lifestyle ...

A new analysis of FDA adverse event reports suggests a potential link between tirzepatide and thyroid cancer. Learn what this ...